Showing results (2011-2020 of 2,072) with videos related to

Sort By:
Pageof 208
Medical Image Analysis|February 17, 2026
A hypergraph-based model for tumor prognosis using local and global information fusion on H&E-stained histology imagesChao Tang, Jun Liu, Yanfen Cui, et al.
Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.
Kidney International Reports|January 1, 2020
2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference ReportAngela Yee-Moon Wang, Tadao Akizawa, Sunita Bavanandan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 20, 2022
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltrationDavid C Wilde, Patricia D Castro, Kaustav Bera, et al.
Theranostics|August 2, 2019
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk FactorsJia-Cheng Lu, Hai-Ying Zeng, Qi-Man Sun, et al.
The Journal of Clinical Investigation|March 2, 2021
Computerized tumor multinucleation index (MuNI) is prognostic in p16+ oropharyngeal carcinomaCan F Koyuncu, Cheng Lu, Kaustav Bera, et al.
Blood|January 11, 2015
A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITPHai Zhou, Miao Xu, Ping Qin, et al.
Hepatology International|November 23, 2022
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, et al.
The Journal of Clinical Investigation|August 26, 2020
dmPFC-vlPAG projection neurons contribute to pain threshold maintenance and antianxiety behaviorsJun-Bin Yin, Shao-Hua Liang, Fei Li, et al.
Chinese Medical Journal|October 21, 2015
Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical TrialYing Mao, Yu Yao, Li-Wei Zhang, et al.
Pageof 208